Skip to content
October 31, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
The Alchemy of Care: Redefining the Patient Experience in Oncology the-alchemy-of-care-redefining-the-patient-experience-in-oncology
  • Survivorship and Post-Treatment

The Alchemy of Care: Redefining the Patient Experience in Oncology

Ammar Sabilarrohman August 13, 2026
Introduction: The "Spa" Paradox In the sterile, often daunting environment of a cancer infusion center, the concept...
Read More Read more about The Alchemy of Care: Redefining the Patient Experience in Oncology
Beyond the Microscope: How DigiM is Revolutionizing Drug Formulation Through Microstructure Intelligence beyond-the-microscope-how-digim-is-revolutionizing-drug-formulation-through-microstructure-intelligence
  • Chemotherapy and Targeted Therapy

Beyond the Microscope: How DigiM is Revolutionizing Drug Formulation Through Microstructure Intelligence

Muslim August 13, 2026
In the high-stakes world of pharmaceutical development, formulation scientists are often caught in a relentless cycle of...
Read More Read more about Beyond the Microscope: How DigiM is Revolutionizing Drug Formulation Through Microstructure Intelligence
Definium Therapeutics Hits Clinical Milestone: DT120 Poised to Redefine Mental Health Treatment definium-therapeutics-hits-clinical-milestone-dt120-poised-to-redefine-mental-health-treatment
  • Chemotherapy and Targeted Therapy

Definium Therapeutics Hits Clinical Milestone: DT120 Poised to Redefine Mental Health Treatment

Laily UPN August 12, 2026
In a transformative week for the burgeoning psychedelics industry, Definium Therapeutics has solidified its position as a...
Read More Read more about Definium Therapeutics Hits Clinical Milestone: DT120 Poised to Redefine Mental Health Treatment
Finding Equilibrium: A Comprehensive Guide to Balancing Effort and Ease Through Restorative Yoga finding-equilibrium-a-comprehensive-guide-to-balancing-effort-and-ease-through-restorative-yoga
  • Integrative Oncology and Holistic Care

Finding Equilibrium: A Comprehensive Guide to Balancing Effort and Ease Through Restorative Yoga

Nana Muazin August 12, 2026
In an era defined by perpetual connectivity and the relentless pace of modern professional and personal life,...
Read More Read more about Finding Equilibrium: A Comprehensive Guide to Balancing Effort and Ease Through Restorative Yoga
Re-evaluating Menopause Hormone Therapy: New Study Unveils Potential Cardiovascular Benefits, Especially for a Stubborn Genetic Risk Factor re-evaluating-menopause-hormone-therapy-new-study-unveils-potential-cardiovascular-benefits-especially-for-a-stubborn-genetic-risk-factor
  • Medical Research and Clinical Trials

Re-evaluating Menopause Hormone Therapy: New Study Unveils Potential Cardiovascular Benefits, Especially for a Stubborn Genetic Risk Factor

Asep Darmawan August 12, 2026
Main Facts The decision to embark on hormone therapy (HT) during the menopausal transition – a pivotal...
Read More Read more about Re-evaluating Menopause Hormone Therapy: New Study Unveils Potential Cardiovascular Benefits, Especially for a Stubborn Genetic Risk Factor
Novo Nordisk’s Cardiovascular Ambitions Stumble: Ziltivekimab Phase 3 Trial Fails to Meet Primary Endpoint novo-nordisks-cardiovascular-ambitions-stumble-ziltivekimab-phase-3-trial-fails-to-meet-primary-endpoint
  • Treatment Innovations

Novo Nordisk’s Cardiovascular Ambitions Stumble: Ziltivekimab Phase 3 Trial Fails to Meet Primary Endpoint

Lina Hope August 12, 2026
In a significant setback for its burgeoning cardiovascular portfolio, pharmaceutical giant Novo Nordisk announced that its investigational...
Read More Read more about Novo Nordisk’s Cardiovascular Ambitions Stumble: Ziltivekimab Phase 3 Trial Fails to Meet Primary Endpoint
From Bench to Bedside: How the Broad Institute is Redefining the Frontiers of Genomic Medicine from-bench-to-bedside-how-the-broad-institute-is-redefining-the-frontiers-of-genomic-medicine
  • Genomics and Precision Medicine

From Bench to Bedside: How the Broad Institute is Redefining the Frontiers of Genomic Medicine

Neng Nana August 12, 2026
In the quiet corridors of laboratories in Cambridge, Massachusetts, a revolution in human health is unfolding. The...
Read More Read more about From Bench to Bedside: How the Broad Institute is Redefining the Frontiers of Genomic Medicine
Bridging the Gap: How Digital Transformation is Revolutionizing Life Sciences Manufacturing Compliance bridging-the-gap-how-digital-transformation-is-revolutionizing-life-sciences-manufacturing-compliance
  • Medical Research and Clinical Trials

Bridging the Gap: How Digital Transformation is Revolutionizing Life Sciences Manufacturing Compliance

Nana Muazin August 12, 2026
The manufacturing floor, often perceived as the engine room of innovation and production, is increasingly being recognized...
Read More Read more about Bridging the Gap: How Digital Transformation is Revolutionizing Life Sciences Manufacturing Compliance
The "Triple-G" Crisis: Eli Lilly Launches Multi-Front War Against the Black Market for Retatrutide the-triple-g-crisis-eli-lilly-launches-multi-front-war-against-the-black-market-for-retatrutide
  • Treatment Innovations

The "Triple-G" Crisis: Eli Lilly Launches Multi-Front War Against the Black Market for Retatrutide

Neng Nana August 12, 2026
As Eli Lilly prepares for the high-stakes regulatory filing of its experimental weight-loss powerhouse, retatrutide—often dubbed the...
Read More Read more about The "Triple-G" Crisis: Eli Lilly Launches Multi-Front War Against the Black Market for Retatrutide
A New Horizon in Oncology: Experimental Immunotherapy Offers Bladder-Sparing Hope for High-Risk Cancer Patients a-new-horizon-in-oncology-experimental-immunotherapy-offers-bladder-sparing-hope-for-high-risk-cancer-patients
  • Clinical Oncology Education

A New Horizon in Oncology: Experimental Immunotherapy Offers Bladder-Sparing Hope for High-Risk Cancer Patients

Rifan Muazin August 12, 2026
For decades, the standard of care for patients with high-risk, non-muscle-invasive bladder cancer (NMIBC) that has failed...
Read More Read more about A New Horizon in Oncology: Experimental Immunotherapy Offers Bladder-Sparing Hope for High-Risk Cancer Patients

Posts pagination

Previous 1 … 403 404 405 406 407 408 409 … 841 Next

Recent Posts

  • AI Breakthrough at UCLA Health Offers Hope for Earlier Detection of Elusive Interval Breast Cancers
  • Geron Halts Late-Stage Myelofibrosis Trial of Rytelo After Efficacy Miss, Shifts Focus to Combination Therapy
  • A Public Servant’s Private Battle: Shona’s Journey from Diagnosis to Advocacy
  • Strengthening the Global Shield: UK and WHO Forge Path Toward Future Pandemic Resilience
  • Genmab’s Strategic Surge: A New Era of Growth Beyond the Darzalex Era

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

ai-breakthrough-at-ucla-health-offers-hope-for-earlier-detection-of-elusive-interval-breast-cancers
  • Medical Research and Clinical Trials

AI Breakthrough at UCLA Health Offers Hope for Earlier Detection of Elusive Interval Breast Cancers

Nana October 31, 2026
geron-halts-late-stage-myelofibrosis-trial-of-rytelo-after-efficacy-miss-shifts-focus-to-combination-therapy
  • Medical Research and Clinical Trials

Geron Halts Late-Stage Myelofibrosis Trial of Rytelo After Efficacy Miss, Shifts Focus to Combination Therapy

Ammar Sabilarrohman October 31, 2026
a-public-servants-private-battle-shonas-journey-from-diagnosis-to-advocacy
  • Patient Advocacy and Support

A Public Servant’s Private Battle: Shona’s Journey from Diagnosis to Advocacy

Laily UPN October 31, 2026
strengthening-the-global-shield-uk-and-who-forge-path-toward-future-pandemic-resilience
  • Breast Cancer Prevention and Lifestyle

Strengthening the Global Shield: UK and WHO Forge Path Toward Future Pandemic Resilience

Asep Darmawan October 31, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.